11 insiders reported 78 Form 4 transactions for Avalo Therapeutics, Inc. (AVTX) over the past 18 months (most recent 2026-07-02). Recent activity: Doyle Mittie (Chief Medical Officer) Buy 1,779 shares, Doyle Mittie (Chief Medical Officer) Buy 2,875 shares, Doyle Mittie (Chief Medical Officer) Sell 4,654 shares, Doyle Mittie (Chief Medical Officer) Buy 1,450 shares, Doyle Mittie (Chief Medical Officer) Sell 1,450 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Buy | 1,779 | $14,303 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Buy | 2,875 | $36,369 |
| 2026-07-02 | Doyle Mittie | Chief Medical Officer | Sell | 4,654 | $93,080 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | Buy | 1,450 | $11,658 |
| 2026-06-25 | Doyle Mittie | Chief Medical Officer | Sell | 1,450 | $26,100 |
| 2026-06-12 | VARKI PAUL | Chief Legal Officer | Sell | 1,081 | $14,161 |
| 2026-06-12 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 138 | $1,808 |
| 2026-06-12 | Doyle Mittie | Chief Medical Officer | Sell | 1,084 | $14,200 |
| 2026-06-12 | Riley Jennifer | Chief Strategy Officer | Sell | 588 | $7,703 |
| 2026-06-01 | Doyle Mittie | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-06-01 | Doyle Mittie | Chief Medical Officer | Sell | 679 | $10,864 |
| 2026-05-19 | Doyle Mittie | Chief Medical Officer | Sell | 3,000 | $56,280 |
| 2026-05-19 | Doyle Mittie | Chief Medical Officer | Buy | 3,000 | $37,950 |
| 2026-05-11 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 18,606 | $183,827 |
| 2026-05-11 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 18,606 | $448,818 |
| 2026-05-07 | VARKI PAUL | Chief Legal Officer | Buy | 62,500 | $839,375 |
| 2026-05-07 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 12,347 | $238,093 |
| 2026-05-07 | Sullivan Christopher Ryan | Chief Financial Officer | Buy | 47,000 | $377,880 |
| 2026-05-07 | Doyle Mittie | Chief Medical Officer | Buy | 1,000 | $12,650 |
| 2026-05-07 | VARKI PAUL | Chief Legal Officer | Buy | 12,563 | $101,007 |
| 2026-05-07 | Doyle Mittie | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-05-07 | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 13,834 | $256,655 |
| 2026-05-07 | VARKI PAUL | Chief Legal Officer | Sell | 37,375 | $706,836 |
| 2026-05-07 | Doyle Mittie | Chief Medical Officer | Sell | 1,679 | $26,864 |
| 2026-05-07 | Chan Mitchell | Director | Sell | 3,167 | $72,461 |
Source: SEC Form 4 filings · as of 2026-07-02